Oh, S. Y., Kim, W. S., Kim, J. S., Kim, S. J., Yoon, D. H., Yang, D., . . . Suh, C. (2019). Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: Consortium for improving survival of lymphoma (CISL) study. Cancer Commun (Lond).
Παραπομπή Chicago StyleOh, Sung Yong, et al. "Phase II Study of R–CVP Followed By Rituximab Maintenance Therapy for Patients With Advanced Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study." Cancer Commun (Lond) 2019.
Παραπομπή MLAOh, Sung Yong, et al. "Phase II Study of R–CVP Followed By Rituximab Maintenance Therapy for Patients With Advanced Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study." Cancer Commun (Lond) 2019.